{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Amrutanjan Health Care Ltd
Markets Rally, But Amrutanjan Health Care Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
Amrutanjan Health Care Ltd’s share price declined to a fresh 52-week low of Rs 500 on 23 March 2026, marking a significant downturn amid broader market weakness and sectoral pressures. The stock’s performance reflects a continuation of recent trends, with the price retreating below key moving averages and underperforming its benchmark indices over the past year.
Five Consecutive Losses Push Amrutanjan Health Care Ltd to a New 52-Week Low
Amrutanjan Health Care Ltd’s stock price declined to a fresh 52-week low of Rs.507.6 on 20 March 2026, marking a significant downturn amid a seven-day losing streak that has seen the share price fall by 8.71% over this period.
Amrutanjan Health Care Ltd Falls to 52-Week Low of Rs.508
Amrutanjan Health Care Ltd’s shares touched a new 52-week low of Rs.508 today, marking a significant decline amid a broader market environment where the Sensex gained 0.51%. The stock’s performance contrasts with the benchmark index, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.
Amrutanjan Health Care Ltd Falls to 52-Week Low of Rs.515.95
Amrutanjan Health Care Ltd’s stock has declined to a fresh 52-week low of Rs.515.95, marking a significant downturn amid a series of consecutive losses. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures despite some positive financial indicators.
Amrutanjan Health Care Ltd Falls to 52-Week Low of Rs 532.5
Shares of Amrutanjan Health Care Ltd fell to a fresh 52-week low of Rs.532.5 today, marking a significant decline amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.
Amrutanjan Health Care Ltd is Rated Hold
Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Amrutanjan Health Care Ltd Falls to 52-Week Low Amid Market Downturn
Amrutanjan Health Care Ltd’s share price declined to a fresh 52-week low of Rs.540.05 today, marking a significant downturn amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.
Amrutanjan Health Care Ltd Falls to 52-Week Low Amid Continued Market Pressure
Shares of Amrutanjan Health Care Ltd have declined to a fresh 52-week low of Rs.556.65, marking a significant downturn amid a broader market weakness. The stock has underperformed its sector and benchmark indices, reflecting a series of recent price declines and ongoing challenges in maintaining upward momentum.
Amrutanjan Health Care Ltd’s Volatile Week: -2.67% Despite Intraday Surge
Amrutanjan Health Care Ltd closed the week ending 20 February 2026 at Rs.615.30, down 2.67% from the previous Friday’s close of Rs.632.15. This decline contrasted with the Sensex’s modest 0.39% gain over the same period, reflecting a week of mixed trading dynamics for the stock amid notable intraday volatility and a significant midweek surge. The stock’s performance was marked by a sharp rebound on 17 February, which reversed a prior three-day decline, before settling into a modest recovery by week’s end.
Amrutanjan Health Care Ltd is Rated Hold by MarketsMOJO
Amrutanjan Health Care Ltd is rated Hold by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Why is Amrutanjan Health Care Ltd falling/rising?
On 27-Feb, Amrutanjan Health Care Ltd witnessed a notable decline in its share price, closing at ₹586.80, down ₹19.55 or 3.22% from the previous session. This drop reflects a broader underperformance relative to its sector and benchmark indices, despite the company’s solid fundamentals and recent positive financial results.
Amrutanjan Health Care Ltd is Rated Hold by MarketsMOJO
Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 18 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Amrutanjan Health Care Ltd Hits Intraday High with 9.12% Surge on 17 Feb 2026
Amrutanjan Health Care Ltd recorded a robust intraday performance on 17 Feb 2026, surging to a day’s high of Rs 661.9, marking a significant 9.12% gain. The stock outperformed its Pharmaceuticals & Biotechnology sector peers and reversed a three-day downward trend, reflecting notable trading momentum amid a broadly subdued market.
Amrutanjan Health Care Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment
Amrutanjan Health Care Ltd commenced trading on 17 Feb 2026 with a significant gap up, opening 8.77% higher than its previous close. This strong start was accompanied by an intraday high of Rs 661.9, marking a 9.12% gain for the day and signalling robust positive momentum in the Pharmaceuticals & Biotechnology sector.
Amrutanjan Health Care Gains 7.48%: Key Drivers Behind This Week’s Rally
Amrutanjan Health Care Ltd delivered a robust weekly performance, rising 7.48% from Rs.574.90 on 2 February to close at Rs.631.90 on 6 February 2026. This gain notably outpaced the Sensex’s 1.51% advance over the same period, reflecting renewed investor interest amid a strong quarterly result and a significant intraday surge midweek. Despite some volatility, the stock demonstrated resilience and short-term strength in a mixed market environment.
Amrutanjan Health Care Ltd is Rated Hold
Amrutanjan Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. While the rating change occurred then, the analysis and financial metrics discussed here reflect the company’s current position as of 07 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Has Amrutanjan Health Care Ltd declared dividend?
Yes, Amrutanjan Health Care Ltd has declared a 100% dividend, amounting to ₹1 per share, with an ex-date of February 6, 2026. While total returns have fluctuated, the company has shown positive returns over the 2 and 5-year periods.
Are Amrutanjan Health Care Ltd latest results good or bad?
Amrutanjan Health Care Ltd's latest Q3 FY26 results show strong net sales growth of 14.90% year-on-year to ₹141.04 crores, but net profit growth is modest at 1.04%, indicating challenges in maintaining profitability despite improved operating margins. Overall, while the performance is strong sequentially, concerns about long-term growth persist.
Amrutanjan Health Care Ltd Hits Intraday High with 11.42% Surge on 4 Feb 2026
Amrutanjan Health Care Ltd recorded a robust intraday performance on 4 Feb 2026, surging 11.42% to touch a day’s high of Rs 610, significantly outperforming the Pharmaceuticals & Biotechnology sector and broader market indices.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
